Jennifer L. Harcourt

CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice.

Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles.

Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.

Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.

Coronavirus antibodies in bat biologists.

Social feedback and the emergence of leaders and followers.

Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.

Leadership, personality and social feedback.

Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Pairs of fish resolve conflicts over coordinated movement by taking turns.

Therapeutic targeting of respiratory syncytial virus G-protein.

Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection.

Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.

Initiative, personality and leadership in pairs of foraging fish.

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice.